Co-Diagnostics CODX
NASDAQ CODX
$0.26 -0.01 (-3.70%)
At close: Nov 13, 2026 · 4:00 PM EST

Co-Diagnostics (CODX) Long-Term Deferred Tax (2019 - 2024)

Updated

Co-Diagnostics' Long-Term Deferred Tax was $7.19 million in Q4 2024, down 13.6% from $8.33 million a year earlier.

Analysis

Co-Diagnostics (CODX) Long-Term Deferred Tax (2019 - 2024) Analysis & Trends

From Q4 2019 onward, Co-Diagnostics has reported Long-Term Deferred Tax for 11 quarters.

  • Long-Term Deferred Tax shows a five-year compound annual growth rate of 6.9% (FY2019 to FY2024).
  • In earlier years, Long-Term Deferred Tax was $8.33 million in FY2023 (+61.9%), $5.14 million in FY2022 and $547,224 in FY2020 (-89.4%).
  • The Q4 2024 figure marks the lowest quarterly Long-Term Deferred Tax since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Co-Diagnostics 1.90 Mn -22.58 Mn -20,463.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 7.19 Mn
Dec 31, 2023 8.33 Mn
Sep 30, 2023 4.27 Mn
Jun 30, 2023 2.01 Mn
Dec 31, 2022 5.14 Mn
Sep 30, 2021 512,552.00
Jun 30, 2021 20,443.00
Mar 31, 2021 244,824.00
Dec 31, 2020 547,224.00
Sep 30, 2020 2.91 Mn
Dec 31, 2019 5.16 Mn
API Access

Co-Diagnostics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=CODX&period=max&api_key=YOUR_API_KEY